XML 39 R5.htm IDEA: XBRL DOCUMENT v3.19.3
Consolidated Statements of Redeemable Convertible Preferred Stock and Stockholders' (Deficit) - USD ($)
$ in Thousands
Total
July 2019 Follow-on Offering [Member]
IPO [Member]
Series Seed Redeemable Convertible Preferred Stock [Member]
Series A Redeemable Convertible Preferred Stock [Member]
Series B Redeemable Convertible Preferred Stock [Member]
Common Stock [Member]
Common Stock [Member]
July 2019 Follow-on Offering [Member]
Common Stock [Member]
IPO [Member]
Additional Paid-in Capital [Member]
Additional Paid-in Capital [Member]
July 2019 Follow-on Offering [Member]
Additional Paid-in Capital [Member]
IPO [Member]
Accumulated Deficit [Member]
Beginning balance at Dec. 31, 2017 $ (23,135)     $ 1,500 $ 25,000         $ 339     $ (23,474)
Beginning balance, shares at Dec. 31, 2017       3,333,333 31,450,499   2,305,173            
Issuance of redeemable convertible preferred stock,           $ 58,257              
Issuance of redeemable convertible preferred stock, shares           28,285,557              
Issuance of series B redeemable convertible preferred stock to settled accrued liability of license cost           $ 500              
Issuance of series B redeemable convertible preferred stock to settle accrued liability of license cost, shares           233,765              
Accretion of issuance costs related to redeemable convertible preferred stock (2,243)         $ 2,243       (339)     (1,904)
Stock-based compensation expense 109                 109      
Vesting of restricted stock awards             $ 30,753            
Net loss (8,242)                       (8,242)
Ending balance at Mar. 31, 2018 (33,511)     $ 1,500 $ 25,000 $ 61,000       109     (33,620)
Ending balance, shares at Mar. 31, 2018       3,333,333 31,450,499 28,519,322 2,335,926            
Beginning balance at Dec. 31, 2017 (23,135)     $ 1,500 $ 25,000         339     (23,474)
Beginning balance, shares at Dec. 31, 2017       3,333,333 31,450,499   2,305,173            
Net loss (30,340)                        
Ending balance at Sep. 30, 2018 137,109           $ 2     192,825     (55,718)
Ending balance, shares at Sep. 30, 2018             23,758,898            
Beginning balance at Mar. 31, 2018 (33,511)     $ 1,500 $ 25,000 $ 61,000       109     (33,620)
Beginning balance, shares at Mar. 31, 2018       3,333,333 31,450,499 28,519,322 2,335,926            
Issuance common stock on public offering, net of issuance or offering costs     $ 104,182           $ 1     $ 104,181  
Issuance common stock on public offering, net of issuance or offering costs, shares                 6,035,151        
Stock-based compensation expense 457                 457      
Vesting of restricted stock awards 0     $ 0 $ 0 $ 0 $ 0     0     0
Vesting of restricted stock awards, shares             30,759            
Net loss (10,507)                       (10,507)
Conversion of redeemable convertible preferred stock into common stock 87,500     $ (1,500) $ (25,000) $ (61,000) $ 1     87,499      
Conversion of redeemable convertible preferred stock into common stock, shares       (3,333,333) (31,450,499) (28,519,322) 15,320,213            
Reclassification of warrants to purchase shares of redeemable convertible preferred stock into warrants to purchase common stock 197                 197      
Ending balance at Jun. 30, 2018 148,318           $ 2     192,443     (44,127)
Ending balance, shares at Jun. 30, 2018             23,722,049            
Exercise of common stock warrant, shares             6,091            
IPO issuance cost difference (168)                 (168)      
Stock-based compensation expense 550                 550      
Vesting of restricted stock awards 0     $ 0 $ 0 $ 0 $ 0     0     0
Vesting of restricted stock awards, shares             30,758            
Net loss (11,591)                       (11,591)
Ending balance at Sep. 30, 2018 137,109           $ 2     192,825     (55,718)
Ending balance, shares at Sep. 30, 2018             23,758,898            
Beginning balance at Dec. 31, 2018 122,184           $ 2     193,921     (71,739)
Beginning balance, shares at Dec. 31, 2018             23,806,628            
Stock-based compensation expense 1,455                 1,455      
Exercise of stock options 252                 252      
Exercise of stock options, shares             116,859            
Vesting of restricted stock awards 0           $ 0     0     0
Vesting of restricted stock awards, shares             30,753            
Net loss (17,103)                       (17,103)
Ending balance at Mar. 31, 2019 106,788           $ 2     195,628     (88,842)
Ending balance, shares at Mar. 31, 2019             23,954,240            
Beginning balance at Dec. 31, 2018 $ 122,184           $ 2     193,921     (71,739)
Beginning balance, shares at Dec. 31, 2018             23,806,628            
Exercise of stock options, shares 232,758                        
Net loss $ (50,303)                        
Ending balance at Sep. 30, 2019 206,760           $ 3     328,799     (122,042)
Ending balance, shares at Sep. 30, 2019             31,606,648            
Beginning balance at Mar. 31, 2019 106,788           $ 2     195,628     (88,842)
Beginning balance, shares at Mar. 31, 2019             23,954,240            
Stock-based compensation expense 1,663                 1,663      
Exercise of stock options 238                 238      
Exercise of stock options, shares             110,290            
Vesting of restricted stock awards 0           $ 0     0     0
Vesting of restricted stock awards, shares             30,757            
Net loss (16,055)                       (16,055)
Ending balance at Jun. 30, 2019 92,634           $ 2     197,529     (104,897)
Ending balance, shares at Jun. 30, 2019             24,095,287            
Issuance common stock on public offering, net of issuance or offering costs   $ 129,465           $ 1     $ 129,464    
Issuance common stock on public offering, net of issuance or offering costs, shares               7,475,000          
Stock-based compensation expense 1,797                 1,797      
Exercise of stock options 9                 9      
Exercise of stock options, shares             5,609            
Vesting of restricted stock awards 0           $ 0     0     0
Vesting of restricted stock awards, shares             30,752            
Net loss (17,145)                       (17,145)
Ending balance at Sep. 30, 2019 $ 206,760           $ 3     $ 328,799     $ (122,042)
Ending balance, shares at Sep. 30, 2019             31,606,648